GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSeed Inc (TSE:7776) » Definitions » Additional Paid-In Capital

CellSeed (TSE:7776) Additional Paid-In Capital : 円1,799.0 Mil(As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is CellSeed Additional Paid-In Capital?


CellSeed's quarterly additional paid-in capital increased from Mar. 2024 (円1,438.8 Mil) to Jun. 2024 (円1,577.9 Mil) and increased from Jun. 2024 (円1,577.9 Mil) to Dec. 2024 (円1,799.0 Mil).

CellSeed's annual additional paid-in capital increased from Dec. 2022 (円447.0 Mil) to Dec. 2023 (円1,363.9 Mil) and increased from Dec. 2023 (円1,363.9 Mil) to Dec. 2024 (円1,799.0 Mil).


CellSeed Additional Paid-In Capital Historical Data

The historical data trend for CellSeed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSeed Additional Paid-In Capital Chart

CellSeed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,570.08 1,770.45 446.96 1,363.89 1,798.97

CellSeed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,269.85 1,363.89 1,438.82 1,577.86 1,798.97

CellSeed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

CellSeed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CellSeed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSeed Business Description

Industry
Traded in Other Exchanges
N/A
Address
Katsura-Bldg, 4F, 3-61, Haramachi, Shinjuku-ku, Tokyo, 162-0053, JPN
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

CellSeed Headlines

No Headlines